Biotech Values

[Biowatch]

OT "for something like anticoagulation, where one needs to fine-tune the degree of the intended repsonse, a target that does not represent a final common pathway or rate-limiting step has the potential to widen the therapeutic index for the desired effect"

It also relates to the "Is it a stroke or brain aneurism?" question that faces people in the ER.